Novel Quinoline and Naphthalene derivatives as potent Antimycobacterial agents

Similar documents
Kd = koff/kon = [R][L]/[RL]

Protein-Ligand Docking Evaluations

User Guide for LeDock

New approaches to scoring function design for protein-ligand binding affinities. Richard A. Friesner Columbia University

5.1. Hardwares, Softwares and Web server used in Molecular modeling

Molecular Modeling Study of Some Anthelmintic 2-phenyl Benzimidazole-1- Acetamides as β-tubulin Inhibitor

The Schrödinger KNIME extensions

ENERGY MINIMIZATION AND CONFORMATION SEARCH ANALYSIS OF TYPE-2 ANTI-DIABETES DRUGS

Supplementary Material. Table of Contents. Evaluation of the test compounds using Lipinski s rule 2

A DFT and ONIOM study of C H hydroxylation catalyzed. by nitrobenzene 1,2-dioxygenase

MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors

Supporting Information. 2-(4-Tolylsulfonyl)ethoxymethyl(TEM) - A New 2 -OH. Protecting Group For Solid Support RNA Synthesis

Protein-Ligand Docking Methods

Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine. JAK2 Selective Mechanism Combined Molecular Dynamics Simulation

3D QSAR analysis of quinolone based s- triazines as antimicrobial agent

Structural insight into the binding of C60-derivatives with enoyl-pyruvate transferase from Helicobacter pylori

Supplementary Figure 1 Preparation of PDA nanoparticles derived from self-assembly of PCDA. (a)

Using AutoDock 4 with ADT: A Tutorial

Supporting Information

Towards Physics-based Models for ADME/Tox. Tyler Day

Tu 1,*, , Sweden

Synthesis of Variously Functionalized Azabicycloalkane Scaffolds by Domino. Metathesis Reactions

The Schrödinger KNIME extensions

5. RESULTS & DISCUSSION

Protein-Ligand Docking Methods

Supplementary Material

Chemical properties that affect binding of enzyme-inhibiting drugs to enzymes

Introduction to Structure Preparation and Visualization

Using Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017

Molecular docking, 3D-QSAR studies of indole hydrazone as Staphylococcus aureus pyruvate kinase inhibitor

STRUCTURAL EXPLORATION AND PHARMACOPHORIC INVESTIGATION OF PYRAZOLE BASED ANALOGS AS NOVEL HISTONE DEACETYLASE 1 INHIBITOR USING COMBINATORIAL STUDIES

Supporting Information

Conformational Searching using MacroModel and ConfGen. John Shelley Schrödinger Fellow

*Corresponding Author *K. F.: *T. H.:

Ch. 9 Practice Questions

Schrödinger Workshop 2012

CHAPTER-5 MOLECULAR DOCKING STUDIES

Volume 12(2)

Supplementary Information

Computational modeling techniques are becoming well. Reranking Docking Poses Using Molecular Simulations and Approximate Free Energy Methods

Chemical properties that affect binding of enzyme-inhibiting drugs to enzymes

Medical Research, Medicinal Chemistry, University of Leuven, Leuven, Belgium.

FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )

3D QSAR and pharmacophore modeling studies on C-2 and C-4 substituted Quinazoline series as Anti-tubercular agents.

Homology modeling. Dinesh Gupta ICGEB, New Delhi 1/27/2010 5:59 PM

Pharmacophore Modeling and Virtual Screening Studies on Colony Stimulating Factor 1 Receptor (CSF1R) Inhibitors

ICM-Chemist-Pro How-To Guide. Version 3.6-1h Last Updated 12/29/2009

A dynamic, luminescent and entangled MOF as a qualitative sensor for volatile. organic solvents and quantitative monitor for acetonitrile vapour

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2009, 6(3),

The PhilOEsophy. There are only two fundamental molecular descriptors

Schrödinger Workshop 2013

Principles of Drug Design

240 Chem. Aromatic Compounds. Chapter 6

Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface

Self-Organizing Molecular Field Analysis on a New Series of COX-2 Selective Inhibitors: 1,5-Diarylimidazoles

April Barry Isralewitz

Principles of Drug Design

MD Simulation in Pose Refinement and Scoring Using AMBER Workflows

SAMPL6 pka Challenge

Supplementary Information

Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA

Supplementary Information

Molecular Mechanics, Dynamics & Docking

Virtual Screening: How Are We Doing?

IDENTIFICATION OF NOVEL INHIBITORS FOR MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 BY VIRTUAL SCREENING AND MOLECULAR DYNAMICS SIMULATION TECHNIQUES

Ligand-receptor interactions

In silico pharmacology for drug discovery

Alchemical free energy calculations in OpenMM

NNScore: A Neural-Network-Based Scoring Function for the Characterization of Protein-Ligand Complexes

Data Mining in Chemometrics Sub-structures Learning Via Peak Combinations Searching in Mass Spectra

The oleocanthal-based homovanillyl sinapate as a novel c-met inhibitor

Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding

Structure-based maximal affinity model predicts small-molecule druggability

Supporting Information

Sumit Kumar a, Liang Gu b, Gabriella Palma b, MandeepKaur* b, Ashona Singh-Pillay c, Parvesh Singh* c and Vipan Kumar* a

Research Article Docking Studies of Binding of Ethambutol to the C-Terminal Domain of the Arabinosyltransferase from Mycobacterium tuberculosis

Binding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces

International Journal of Chemistry and Pharmaceutical Sciences

CHEM 4170 Problem Set #1

Molecular Interactions F14NMI. Lecture 4: worked answers to practice questions

Docking. GBCB 5874: Problem Solving in GBCB

Yongmei Pan, Yanli Wang,* and Stephen H. Bryant* INTRODUCTION

10 Introduction to organic chemistry

Other Cells. Hormones. Viruses. Toxins. Cell. Bacteria

1. INTRODUCTION. Received: February 24, Article. pubs.acs.org/jcim

Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G2019S.

( ) 2 75( ) 3

Research Article. Binding modes study on enantiomers of BYK as potassiumcompetitive

Structural Bioinformatics (C3210) Molecular Mechanics

Hit Finding and Optimization Using BLAZE & FORGE

Computational chemical biology to address non-traditional drug targets. John Karanicolas

Docking of Protein Kinase B Inhibitors: Implications in the Structure-Based Optimization of a Novel Scaffold

Design and Synthesis of Novel Bicalutamide and Enzalutamide Deriva:ves as An:prolifera:ve Agents for the Treatment of Prostate Cancer.

Using AutoDock for Virtual Screening

Chem 1140; Molecular Modeling

Structure based drug design and LIE models for GPCRs

Virtual screening in drug discovery

BCB410 Protein-Ligand Docking Exercise Set Shirin Shahsavand December 11, 2011

Be H. Delocalized Bonding. Localized Bonding. σ 2. σ 1. Two (sp-1s) Be-H σ bonds. The two σ bonding MO s in BeH 2. MO diagram for BeH 2

Build_model v User Guide

Transcription:

ovel Quinoline and aphthalene derivatives as potent Antimycobacterial agents Ram Shankar Upadhayaya a, Jaya Kishore Vandavasi a, Ramakant A. Kardile a, Santosh V. Lahore a, Shailesh S. Dixit a, Hemantkumar S. Deokar a, Popat D. Shinde a, Manash P. Sarmah a and Jyoti Chattopadhyaya b, * a Institute of Molecular Medicine, Pune 411 057, India b Program of Bioorganic Chemistry, Institute of Cell and Molecular Biology, Biomedical Centre, Uppsala University, Sweden S1

Sr. o. Contents Page o. 1 1 H-MR spectra of compound 2 S8 2 D 2 -MR spectra of compound 2 S9 3 13 C-MR spectra of compound 2 S10 4 LCMS spectra of compound 2 S11 5 HPLC spectra of compound 2 S12 6 1 H-MR spectra of compound 3 S13 7 13 C-MR spectra of compound 3 S14 8 LCMS spectra of compound 3 S15 9 MASS spectra of compound 3 S16 10 HPLC spectra of compound 3 S17 11 1 H-MR spectra of compound 4 S18 12 13 C-MR spectra of compound 4 S19 13 LCMS spectra of compound 4 S20 14 MASS spectra of compound 4 S21 15 HPLC spectra of compound 4 S22 16 1 H-MR spectra of compound 5 S23 17 13 C-MR spectra of compound 5 S24 18 DEPT-MR spectra of compound 5 S25 19 MASS spectra of compound 5 S26 20 1 H-MR spectra of compound 6 S27 21 13 C-MR spectra of compound 6 S28 22 DEPT-MR spectra of compound 6 S29 23 LCMS spectra of compound 6 S30 24 MASS spectra of compound 6 S31 25 HPLC spectra of compound 6 S32 26 1 H-MR spectra of compound 7 S33 27 13 C-MR spectra of compound 7 S34 28 DEPT-MR spectra of compound 7 S35 29 LCMS spectra of compound 7 S36 30 MASS spectra of compound 7 S37 S2

31 HPLC spectra of compound 7 S38 32 1 H-MR spectra of compound 8 S39 33 13 C-MR spectra of compound 8 S40 34 DEPT-MR spectra of compound 8 S41 35 MASS spectra of compound 8 S42 36 1 H-MR spectra of compound 9 S43 37 D 2 -MR spectra of compound 9 S44 38 13 C-MR spectra of compound 9 S45 39 DEPT-MR spectra of compound 9 S46 40 LCMS spectra of compound 9 S47 41 MASS spectra of compound 9 S48 42 HPLC spectra of compound 9 S49 43 1 H-MR spectra of compound 10 S51 44 D 2 -MR spectra of compound 10 S52 45 13 C-MR spectra of compound 10 S53 46 DEPT-MR spectra of compound 10 S54 47 LCMS spectra of compound 10 S55 48 HPLC spectra of compound 10 S56 49 1 H-MR spectra of compound 11 S58 50 D 2 -MR spectra of compound 11 S59 51 13 C-MR spectra of compound 11 S60 52 DEPT-MR spectra of compound 11 S61 53 LCMS spectra of compound 11 S62 54 MASS spectra of compound 11 S63 55 HPLC spectra of compound 11 S64 56 1 H-MR spectra of compound 12 S65 57 D 2 -MR spectra of compound 12 S66 58 13 C-MR spectra of compound 12 S67 59 DEPT-MR spectra of compound 12 S68 60 LCMS spectra of compound 12 S69 61 MASS spectra of compound 12 S70 S3

62 HPLC spectra of compound 12 S71 63 1 H-MR spectra of compound 13 S72 64 D 2 -MR spectra of compound 13 S73 65 13 C-MR spectra of compound 13 S74 66 DEPT-MR spectra of compound 13 S75 67 LCMS spectra of compound 13 S76 68 MASS spectra of compound 13 S77 69 HPLC spectra of compound 13 S78 70 1 H-MR spectra of compound 14 S79 71 D 2 -MR spectra of compound 14 S80 72 13 C-MR spectra of compound 14 S81 73 DEPT-MR spectra of compound 14 S82 74 LCMS spectra of compound 14 S83 75 MASS spectra of compound 14 S84 76 HPLC spectra of compound 14 S85 77 1 H-MR spectra of compound 15 S87 78 D 2 -MR spectra of compound 15 S88 79 13 C-MR spectra of compound 15 S89 80 DEPT-MR spectra of compound 15 S90 81 LCMS spectra of compound 15 S91 82 MASS spectra of compound 15 S92 83 HPLC spectra of compound 15 S93 84 1 H-MR spectra of compound 16 S94 85 D 2 -MR spectra of compound 16 S95 86 13 C-MR spectra of compound 16 S96 87 DEPT-MR spectra of compound 16 S97 88 LCMS spectra of compound 16 S98 89 MASS spectra of compound 16 S99 90 HPLC spectra of compound 16 S100 91 1 H-MR spectra of compound 17 S101 92 D 2 -MR spectra of compound 17 S102 S4

93 13 C-MR spectra of compound 17 S103 94 DEPT-MR spectra of compound 17 S104 95 LCMS spectra of compound 17 S105 96 MASS spectra of compound 17 S106 97 HPLC spectra of compound 17 S107 98 1 H-MR spectra of compound 18 S109 99 D 2 -MR spectra of compound 18 S110 100 13 C-MR spectra of compound 18 S111 101 DEPT-MR spectra of compound 18 S112 102 LCMS spectra of compound 18 S113 103 MASS spectra of compound 18 S114 104 HPLC spectra of compound 18 S115 105 1 H-MR spectra of compound 19 S116 106 13 C-MR spectra of compound 19 S117 107 DEPT-MR spectra of compound 19 S118 108 LCMS spectra of compound 19 S119 109 HPLC spectra of compound 19 S120 110 1 H-MR spectra of compound 21 S121 111 13 C-MR spectra of compound 21 S122 112 DEPT-MR spectra of compound 21 S123 113 LCMS spectra of compound 21 S124 114 HPLC spectra of compound 21 S125 115 1 H-MR spectra of compound 22 S126 116 D 2 -MR spectra of compound 22 S127 117 13 C-MR spectra of compound 22 S128 118 DEPT-MR spectra of compound 22 S129 119 LCMS spectra of compound 22 S130 120 HPLC spectra of compound 22 S131 121 1 H-MR spectra of compound 23 S133 122 D 2 -MR spectra of compound 23 S134 123 13 C-MR spectra of compound 23 S135 S5

124 DEPT-MR spectra of compound 23 S136 125 MASS spectra of compound 23 S137 126 HPLC spectra of compound 23 S138 127 1 H-MR spectra of compound 24 S140 128 D 2 -MR spectra of compound 24 S141 129 13 C-MR spectra of compound 24 S142 130 DEPT-MR spectra of compound 24 S143 131 LCMS spectra of compound 24 S144 132 HPLC spectra of compound 24 S145 133 1 H-MR spectra of compound 25 S146 134 D 2 -MR spectra of compound 25 S147 135 13 C-MR spectra of compound 25 S148 136 DEPT-MR spectra of compound 25 S149 137 LCMS spectra of compound 25 S150 138 HPLC spectra of compound 25 S151 139 1 H-MR spectra of compound 26 S152 140 D 2 -MR spectra of compound 26 S153 141 13 C-MR spectra of compound 26 S154 142 DEPT-MR spectra of compound 26 S155 143 LCMS spectra of compound 26 S156 144 MASS spectra of compound 26 S157 145 HPLC spectra of compound 26 S158 146 1 H-MR spectra of compound 27 S159 147 D 2 -MR spectra of compound 27 S160 148 13 C-MR spectra of compound 27 S161 149 DEPT-MR spectra of compound 27 S162 150 MASS spectra of compound 27 S163 151 HPLC spectra of compound 27 S164 152 1 H-MR spectra of compound 28 S166 153 D 2 -MR spectra of compound 28 S167 154 13 C-MR spectra of compound 28 S168 S6

155 DEPT-MR spectra of compound 28 S169 156 LCMS spectra of compound 28 S170 157 HPLC spectra of compound 28 S171 158 1 H-MR spectra of compound 29 S172 159 D 2 -MR spectra of compound 29 S173 160 13 C-MR spectra of compound 29 S174 161 DEPT-MR spectra of compound 29 S175 162 LCMS spectra of compound 29 S176 163 HPLC spectra of compound 29 S177 164 1 H-MR spectra of compound 30 S178 165 D 2 -MR spectra of compound 30 S179 166 13 C-MR spectra of compound 30 S180 167 DEPT-MR spectra of compound 30 S181 168 LCMS spectra of compound 30 S182 169 HPLC spectra of compound 30 S183 170 Computational Methods S185 S7

Ar-CH 3 2 Ar-H Ar-H Ar- S8

Ar-CH 3 2 Ar-H Ar-H S9

Ar-CH 3 2 Ar-C Ar-C Ar-C S10

2 S11

2 S12

3 Ar-H Ar-H Ar-CH 3 S13

3 Ar-C Ar-C Ar-CH 3 S14

3 S15

3 S16

3 S17

H 4 Ar-H Ar-H Ar-CH 3 S18

H 4 Ar-H Ar-H Ar-CH Ar-CH 3 S19

H 4 S20

H 4 S21

H 4 S22

Ar-CH 3 5 Ar-H Ar-CHCH 2 epoxy-ch 2 CHCH 2 epoxy-ch S23

Ar-H 5 Ar-CHCH 2 CHCH 2 epoxy-ch epoxy-ch 2 Ar-CH 3 S24

Ar-H 5 Ar-CHCH 2 epoxy-ch CHCH 2 epoxy-ch 2 Ar-CH 3 S25

5 S26

Ar-CH 3 Ar-H 6 CH 2 CHCH 2 CH CH=CH 2 CH 2 S27

6 Ar-C CH 2 CHCH 2 Ar-CH Ar-CCH=CH 2 CH 2 Ar-CH 3 S28

6 Ar-C CH 2 CHCH 2 Ar-C Ar-CH CH 2 Ar-CH 3 CH=CH 2 S29

6 S30

6 S31

6 S32

Ar-CH 3 7 Ar-H CH -CH 2 CH- CH 2 CH 2 S33

-CH 2 7 Ar-C Ar-CHCH 2 CH 2 CH CH- Ar-CH 3 S34

7 Ar-C Ar-CHCH 2 CH- Ar-CH 3 CH 2 CH -CH 2 S35

7 S36

7 S37

7 S38

CH 2 CH -CH 2 CH -CH 2 CH 8 Ar-H Ar-CHCH 2 Ar-CH 3 S39

8 Ar-C -CH 2 CH Ar-CHCH 2 -CH 2 CH Ar-CH 3 Ar-CHCH 2 S40

Ar-C Ar-CHCH 2 -CH 2 CH 8 Ar-CH 3 Ar-CHCH 2 -CH 2 CH S41

8 S42

9 Ar-H Ar-CHCH 2 Ar-CH 2 & CH Ar-CHCH 2 & Ar-CH 3 S43

Ar-H 9 Ar-CH 3 Ar-CH 2 & Ar-CHCH 2 CH Ar-CHCH 2 S44

9 Ar-C Ar-CHCH 2 Ar-CHCH 2 Ar-CH 2 CH Ar-CH 3 S45

9 Ar-C Ar-CHCH 2 CH Ar-CH 3 Ar-CHCH 2 Ar-CH 2 S46

9 S47

9 S48

9 S49

9 S50

Ar-CH 2 & CH CH Ar-CHCH 2 10 Ar-H Ar-CHCH 2 Ar-CH 3 S51

10 Ar-H Ar-CHCH 2 Ar-CH 2 & CH Ar-CHCH 2 Ar-CH 3 S52

10 Ar-C Ar-CHCH 2 Ar-CH 3 Ar-CHCH 2 CH Ar-CH 2 S53

Ar-C CH Ar-CHCH 2 Ar-CH 3 Ar-CHCH 2 Ar-CH 2 10 S54

10 S55

10 S56

10 S57

Ar-CH 3 11 Ar-H Ar-CHCH 2 Ar-CH 2 & CH Ar-CHCH 2 & CH S58

Ar-CH 3 11 Ar-H Ar-CH 2 Ar-CHCH 2 & CH Ar-CHCH 2 Ar-CH 3 S59

11 Ar-C Ar-CHCH 2 Ar-CHCH 2 Ar-CH 3 Ar-CH 2 CH S60

Ar-C Ar-CHCH 2 CH Ar-CH 3 Ar-CHCH 2 Ar-CH 2 11 S61

11 S62

11 S63

11 S64

H Ar-CH 3 12 H Ar-H Ar-CHCH 2 Ar-H Ar-CHCH 2, CH & H HCH 2 S65

12 H H Ar-CH 3 Ar-H Ar-CHCH 2 Ar-CHCH 2, CH HCH 2 S66

H 12 H Ar-C Ar-CHCH 2 Ar-CHCH 2, CH HCH 2 Ar-CH 3 S67

H Ar-C 12 H Ar-CHCH 2 CH Ar-CH 3 Ar-CHCH 2, HCH 2 S68

H 12 H S69

H 12 H S70

H 12 H S71

Ar-CH 3 H 13 H Ar-H Triazole- H Ar-CHCH 2 Ar-CHCH 2 & CH CH2H HCH 2 S72

13 H Ar-H Ar-CHCH 2 H Ar-CHCH 2 & CH HCH 2 Ar-CH 3 S73

13 H H Ar-C Ar-CHCH 2 Ar-CHCH 2 & CH HCH 2 Ar-CH 3 S74

H 13 H Ar-C Ar-CHCH 2 CH Ar-CH 3 Ar-CHCH 2 HCH 2 S75

H 13 H S76

H 13 H S77

H 13 H S78

14 Ar-H Ar-CHCH 2, Py-(CH 2 ) 2 & CH Ar-CH 3 & CH 2 CH Ar-CHCH 2 CH 2 CH CH 2 (CH 2 ) 2 S79

14 Ar-H Ar-CHCH 2 Ar-CHCH 2, Py-(CH 2 ) 2 & CH Ar-CH 3 & CH 2 CH CH 2 (CH 2 ) 2 CH 2 CH S80

CH 2 CH PyCH 2 CH 2 14 Ar-C Ar-CHCH 2 Ar-CHCH 2 CH 2 -(CH 2 ) 2 Ar-CH 3 S81

Ar-CHCH 2 CH 2 CH PyCH 2 CH 2 CH 2 -(CH 2 ) 2 14 Ar-C Ar-CHCH 2 CH 2 CH Ar-CH 3 S82

14 S83

14 S84

14 S85

14 S86

Ar-CH 3 15 Ar-H Pyrazole-H, Ar-CHCH 2 CH 2 CH Ar-CHCH 2 Pyrazole-CH 3 S87

Ar-CH 3 15 Ar-H Pyrazole-H, Ar-CHCH 2 CH 2 CH Ar-CHCH 2 Pyrazole-CH 3 S88

15 Ar-C Ar-CH 3 CH 2 CH Ar-CHCH 2 Pyrazole-CH 3 CH 2 CH S89

Ar-C CH 2 CH Ar-CHCH 2 Ar-CH 3 Pyrazole-CH 3 15 CH 2 CH CH 2 CH S90

15 S91

15 S92

15 S93

CH 3 Ar-CH 3, CH 2 HCH 2 H 16 Ar-H Ar-CHCH 2 CH 2 CH(), CH 3 CH 2 HCH 2 CH CH S94

H CH 3 Ar-CH 3, CH 2 HCH 2 16 Ar-H Ar-CHCH 2 CH 2 CH(), CH 3 CH 2 CH S95

CH 2 CH() CH 3 CH 2 CH CH 3 CH()CH 2 H HCH 2 CH H 16 Ar-C Ar-CH 3, Ar-CHCH 2 S96

CH CH 3 CH 2 CH() CH 3 CH 2 CH()CH 2 H HCH 2 CH H 16 Ar-C Ar-CHCH 2 Ar-CH 3, S97

H 16 S98

H 16 S99

H 16 S100

CH Ar-CHCH 2, CH 2 CH()CH 2 (CH 3 )CH 2 17 H Ar-H Ar-CHCH 2 Ar-CH 3 -CH 3, CH 2 S101

Ar-CHCH 2, CH 2 CH()CH 2 (CH 3 )CH 2 CH Ar-CH 3 -CH 3, CH 2 17 H Ar-H Ar-CHCH 2 S102

Ar-CHCH 2, CH (CH 3 )CH 2 CH 2 CH()CH 2 CH 2 Ar-C 17 H Ar-CHCH 2 -CH 3, Ar-CH 3 S103

Ar-CHCH 2, CH()CH 2 (CH 3 )CH 2 CH 2 CH 2 17 H Ar-C Ar-CHCH 2 CH -CH3, Ar-CH 3 S104

17 H S105

17 H S106

17 H S107

17 H S108

Ar-CHCH 2 CH() Tetrazole-H CH CH 2 CH()CH 2 H H 18 H Ar-H Ar-CH 3 Ar-CHCH 2, Ar-H S109

Ar-CHCH 2 CH() CH 2 CH()CH 2 H 18 H H Ar-H Ar-CHCH 2, Ar-CH 3 S110

H 18 H Ar-C Ar-CHCH 2 Ar-CHCH 2 CH CH 2 H Ar-CH 3 S111

H 18 H Ar-C Ar-CHCH 2 CH Ar-CH 3 Ar-CHCH 2 CH 2 H S112

H 18 H S113

H 18 H S114

H 18 H S115

H 2 CH 2 CH 2 HCH 2 CH 2 CH 2 H H 19 H 2 Ar-H Ar-CHCH 2, Ar-CH 3, H 2 CH 2, CH ()CHCH 2 CH CH 2 HCH 2 S116

Ar-CHCH 2 Ar-CHCH 2 CH CH()CH 2 H CH 2 CH 2 H H Ar-C Ar-CH 3 19 H 2 H 2 CH 2 S117

Ar-CHCH 2 CH Ar-CHCH 2 CH()CH 2 H CH 2 CH 2 H H 19 H 2 Ar-C Ar-CH 3 H 2 CH 2 S118

H 19 H 2 S119

H 19 H 2 S120

21 Ar-H Ar-CHCH 2 epoxy-ch CH 2 CH- epoxy-ch 2 S121

Ar-C 21 Ar-CHCH 2 CH 2 CH- epoxy-ch epoxy-ch 2 S122

21 Ar-C Ar-CHCH 2 epoxy-ch CH 2 CH- epoxy-ch 2 S123

21 S124

21 S125

CH 2 CH CH Ar-H CH 3 Piperazine-CH 2 22 ArCHCH 2 CH 2 CH, Piperazine-CH 2 S126

CH 2 CH 22 Ar-H CH 3 Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 ArCHCH 2 S127

CH 2 CH 22 Ar-C ArCHCH 2 HCH Piperazine-CH 2 ArCHCH 2 CH 3 Piperazine-CH 2 CH 2 CH S128

Ar-C 22 ArCHCH 2 HCH CH 3 ArCHCH 2 Piperazine-CH 2 S129

22 S130

22 S131

22 S132

23 CH 3 Ar-H ArCHCH 2 CH CH 2 CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 S133

23 CH 3 Ar-H Piperazine-CH 2 ArCHCH 2 CH 2 CH CH 2 CH, Piperazine-CH 2 S134

23 Ar-C ArCHCH 2 CH 3 CH 2 CH CH CH 2 CH Piperazine-CH 2 S135

Ar-C ArCHCH 2 23 CH CH 3 CH 2 CH CH 2 CH Piperazine-CH 2 S136

23 S137

23 S138

23 S139

24 Ar-H Piperazine-CH 2, CH F 3 C ArCHCH 2 CH 2 CH CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 S140

24 Ar-H Piperazine-CH 2 F 3 C ArCHCH 2 CH 2 CH Piperazine-CH 2 CH CH 2 CH, Piperazine-CH 2 S141

24 Ar-C Piperazine-CH 2 F 3 C ArCHCH 2 CH 2 CH, CH CH 2 CH S142

24 F 3 C Ar-C ArCHCH 2 CH CH 2 CH CH 2 CH, Piperazine-CH 2 S143

24 F 3 C S144

24 F 3 C S145

25 Cl Cl Ar-H ArCHCH 2 Piperazine-CH 2 CH 2 CH CH CH 2 CH, Piperazine-CH 2, CH S146

25 Ar-H Piperazine-CH 2 Cl Cl ArCHCH 2 CH CH 2CH CH 2 CH, Piperazine-CH 2 S147

Ar-C Piperazine-CH 2 25 Cl Cl CH 2 CH, ArCHCH 2 CH CH 2 CH S148

25 Ar-C Cl Cl ArCHCH 2 CH CH 2 CH CH 2 CH, Piperazine-CH 2 S149

25 Cl Cl S150

25 Cl Cl S151

Ar-H 26 ArCHCH 2 -CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2, CH CH2 CH CH S152

Ar-H 26 -CH Piperazine-CH 2 ArCHCH 2 CH CH2 CH CH 2 CH, Piperazine-CH 2, S153

Ar-C 26 ArCHCH 2 Piperazine-CH 2 CH CH 2 CH CH CH 2 CH S154

26 Ar-C ArCHCH 2 CH CH CH 2 CH CH 2 CH Piperazine-CH2 S155

26 S156

26 S157

26 S158

27 Ar-H CH 2 CH Piperazine-CH 2 ArCHCH 2 -CH 2 Ph CH CH 2 CH, Piperazine-CH 2, CH S159

27 Ar-H CH 2 CH Piperazine-CH 2 ArCHCH 2 CH -CH 2 Ph CH 2 CH, Piperazine-CH 2, S160

27 Ar-C ArCHCH 2 Piperazine-CH 2 CH 2 Ph CH 2 CH CH 2 CH CH S161

27 Ar-C ArCHCH 2 CH CH 2 Ph Piperazine-CH 2 CH 2 CH CH 2 CH S162

27 S163

27 S164

27 S165

Ar-H 28 Piperazine-CH 2, CH 2 CH ArCHCH 2 CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 S166

28 Ar-H Piperazine-CH 2, CH 2 CH Piperazine-CH 2 ArCHCH 2 CH CH 2 CH, Piperazine-CH 2 S167

Ar-C 28 Piperazine-CH 2 ArCHCH 2 CH 2 Ph CH CH 2 CH S168

Ar-C 28 ArCHCH 2 CH CH 2 CH CH 2 Ph Piperazine-CH 2 S169

28 S170

28 S171

Ar-H 29 Piperazine-CH 2, CH 2 CH F ArCHCH 2 CH 2 CH CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 S172

Ar-H 29 Piperazine-CH 2, CH 2 CH F ArCHCH 2 CH CH 2 CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 S173

Ar-C Piperazine-CH 2 29 F ArCHCH 2 CH 2 Ph CH CH 2 CH S174

29 F Ar-C ArCHCH 2 CH CH 2 CH CH 2 Ph Piperazine-CH 2 S175

29 F S176

29 F S177

30 Ar-H Cl ArCHCH 2 CH CH 2 CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 S178

30 Cl Ar-H ArCHCH 2 CH CH 2 CH Piperazine-CH 2 CH 2 CH, Piperazine-CH 2 S179

30 Ar-C Piperazine-CH 2 Cl ArCHCH 2 CH 2 Ph CH CH 2 CH S180

Ar-C ArCHCH 2 CH CH 2 CH CH 2 Ph Piperazine-CH 2 30 Cl S181

30 Cl S182

S183

30 Cl S184

Computational Methods Docking study has been carried out using GLIDE (Grid Based Ligand Docking with Energetics). 1,2 All molecules were built within maestro 3 by using build, they are minimized with minimization cycle for conjugate gradient and steepest descent with default value 0.05 Ǻ for initial step size and 1.00Ǻ for maximum step size. In convergence criteria for the minimization both the energy change criteria and gradient criteria was used with default values 10-7 kcal/mol and 0.001 kcal/mol respectively. A homology model ATP-synthase from M. tuberculosis 4 was used for docking. A restrained minimization using the PLS- 2005 force field was performed for the refinement of the homology model. This minimization continued until an average rms deviation of the non-hydrogen atoms reached the specified limit of 0.3Å. Then a grid file of 20Å was generated using putative binding site located between subunit-a and subunit-c. All docking calculations were run in the Extra Precision (XP) mode and XP Glide scoring function was used to assess the binding affinity prediction of the ligand at the active site. Glide XP Score is modified form of ChemScore function and written as Eq. I Glide XP Score = Ecoul +E vdw + E bind + E penalty... Eq. I E bind = E hyd_enclosure + E hb_nn_motif + E PI + E hb_pair + E phobic _pair... Eq.II E penalty = E desolv + E ligand _strain... Eq.III References: 1. Glide, version 5.5; Schrödinger, L. L. C.: ew York, USA. S185

2. Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.; Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. J. Med. Chem. 2006, 49, 6177-6196. 3. Maestro, version 9.0; Schrödinger, L. L. C.: ew York, USA. 4. Upadhayaya, R. S.; Kulkarni, G. M; Jaya Kishore, V.; ageswara Rao, V.; Sharma, V.; Dixit, S. S.; Chattopadhaya, J. Bioorg. Med. Chem. 2009, 17, 4681-4692. S186